GlassScriptPhysician profile
Amy J Burke
NPI 1952563439
$18,776.27
in general payments reported to CMS, 2019-2025
54 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,724 · 2020: $2,708 · 2021: $3,110 · 2022: $2,778 · 2023: $2,445 · 2024: $2,212 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,455 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,455.02 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,288.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,907.70 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,765.82 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $1,683.42 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,402.87 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $1,347.01 | 2019-2025 | Prolia, Evenity, Otezla |
| Pfizer INC. | $893.40 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $890.73 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Astellas Pharma US INC | $599.65 | 2019-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $534.10 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $523.25 | 2019-2023 | |
| Daiichi Sankyo INC. | $497.25 | 2019-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $363.48 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $350.85 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $334.09 | 2022-2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $321.14 | 2019-2022 | |
| Allergan, INC. | $276.51 | 2020 | |
| Abbott Laboratories | $225.21 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Currax Pharmaceuticals LLC | $192.97 | 2021-2025 | Contrave |
| Amarin Pharma, INC. | $176.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $163.73 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $146.77 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $146.20 | 2023-2025 | Cologuard Collection Kit |
| Genzyme Corporation | $141.48 | 2024 | |
| Esperion Therapeutics, INC. | $134.49 | 2020-2021 | |
| Edwards Lifesciences Corporation | $119.09 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Teva Pharmaceuticals USA, INC. | $117.12 | 2019-2021 | |
| Integra Lifesciences Corporation | $115.29 | 2019 | |
| Impel Pharmaceuticals INC. | $113.76 | 2023 | Trudhesa |
| Phathom Pharmaceuticals, INC. | $113.02 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $110.13 | 2024-2025 | Auvelity, Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $85.02 | 2020-2024 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.31 | 2025 | Caplyta |
| Dexcom, INC. | $70.69 | 2024-2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $61.47 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $41.21 | 2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $39.64 | 2019-2024 | Eliquis |
| Vbi Vaccine (Delaware) INC. | $34.96 | 2023 | Prehevbrio |
| Sanofi Pasteur INC. | $33.71 | 2019-2022 | |
| Eisai INC. | $33.69 | 2019-2021 | |
| Therapeuticsmd, INC. | $29.45 | 2020 | |
| Gilead Sciences, INC. | $28.89 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $26.89 | 2021 | |
| Radius Health, INC. | $24.32 | 2020 | |
| Lundbeck LLC | $23.91 | 2024 | Rexulti |
| Inspire Medical Systems, INC. | $23.81 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $23.07 | 2025 | Aptima |
| Promius Pharma LLC | $20.47 | 2019 | |
| Mylan Specialty L.P. | $19.97 | 2019 | |
| Tactile Systems Technology INC | $19.65 | 2022 | |
| Circassia INC. | $18.69 | 2019 | |
| Optinose US, INC. | $17.61 | 2019 | |
| Corcept Therapeutics | $16.76 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.